The story of Viagra presents a challenging picture for shareholders. While the initial launch generated significant gains, the expiration of its exclusive rights opened the floodgates to generic versions, dramatically https://thebookmarkfree.com/story21740410/the-copyright-and-big-pharma-a-volatile-bet